Skip to main content
Premium Trial:

Request an Annual Quote

IP Watch: Siemens, Hologic, Samsung, Illumina, Others Win US Patents


Siemens has been awarded US Patent No. 8,715,924, "Process for determining the concentration of nucleic acids."

Walter Gumbrecht, Jorn Mosner, and Sebastian Schmidt are named as inventors.

Loma Linda University has been awarded US Patent No. 8,715,926, "Biomarkers for the detection of head and neck tumors."

Penelope Duerksen-Hughes, Maria Filippova, and Valeri Filippov are named as inventors.

US Department of Health and Human Services has been awarded US Patent No. 8,715,928, "Molecular-based method of cancer diagnosis and prognosis."

Steven Libutti and Mei He are named as inventors.

The Johns Hopkins University has been awarded US Patent No. 8,715,934, "Single-molecule PCR on microparticles in water-in-oil emulsions."

Frank Diehl, Kenneth Kinzler, and Bert Vogelstein are named as inventors.

Universidad de Barcelona has been awarded US Patent No. 8,715,935, "Standardized method and kit for the quantification of hepatitis A virus."

Albert Bosch Navarro and Rosa Pinto Sole are named as inventors.

Medical Diagnostic Laboratories has been awarded US Patent No. 8,715,936, "Method of determining types I, II, III, IV or V or methicillin-resistant Staphylococcus aureus (MRSA) in a biological sample."

Scott Gygax, Christina Overmyer, Lisa DeSalvia, Martin Adelson, and Eli Mordechai are named as inventors.

Exact Sciences has been awarded US Patent No. 8,715,937, "Mutation detection assay."

Hongzhi Zou, Graham Lidgard, Michael Domanico, and Hatim Allawi are named as inventors.

Gen-Probe (Hologic) has been awarded US Patent No. 8,715,939, "Compositions, methods, and kits to detect adenovirus nucleic acids."

Emily Ziegler and Jessica Townsend are named as inventors.

Samsung Electronics has been awarded US Patent No. 8,715,965, "Method of amplifying nucleic acid from blood."

Hun-joo Lee, Sung-young Jeong, Joon-ho Kim, and Kyu-youn Hwang are named as inventors.

Illumina has been awarded US Patent No. 8,715,966, "Preparation of templates for nucleic acid sequencing."

Liu Xiaohai, John Milton, Geoffrey Smith, Colin Barnes, Isabelle Rasolonjatovo, Roberto Rigatti, Xiaolin Wu, Tobias Ost, Graham Worsley, David Earnshaw, Gerardo Turcatti, and Anthony Romieu are named as inventors.

Population Genetics Technologies has been awarded US Patent No. 8,715,967, "Method for accurately counting starting molecules."

James Casbon, Sydney Brenner, Robert Osborne, Conrad Lichtenstein, and Andreas Claas are named as inventors.

New England Biolabs has been awarded US Patent No. 8,715,987, "Solubilized phospholipids for stabilizing nucleic acid polymerases."

Donald Johnson and Thomas Evans, Jr. are named as inventors.

Roche has been awarded US Patent No. 8,715,991, "DNA polymerases with increased 3'-mismatch discrimination."

Fred Reichert, Keith Bauer, and Thomas Myers are named as inventors.

Micronics has been awarded US Patent No. 8,716,007, "Portable high gain fluorescence detection system."

Frederick Battrell, Troy Daiber, and William Hunter are named as inventors.

Advanced Liquid Logic has been awarded US Patent No. 8,716,015, "Manipulation of cells on a droplet actuator."

Michael Pollack, Vamsee Pamula, and Allen Eckhardt are named as inventors.

Affymetrix has been awarded US Patent No. 8,716,190, "Amplification and analysis of selected targets on solid supports."

Glenn Fu, Glenn McGall, Robert Kuimelis, Jing Hu, and Pei-Hua Wang are named as inventors.

Ganymed Pharmaceuticals has been awarded US Patent No. 8,716,455, "Genetic products differentially expressed in tumors and use thereof."

Ugur Sahin, Ozlem Tureci, and Michael Koslowski are named as inventors.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.